glp 1 function in the body Use of Glucagon-Like Peptide-1 Current Insights, Advantages and Challenges
Description
& Palma, J
You might leave food on your plate for the first time in years
However, 47% of those with diabetes and 36% with obesity who discontinued these medications restarted them again within a year
Int J Obes Suppl (2019) 9(1):6572
G.PechtnerV
Most users report no side effects
